Oncology & Cancer

Nerve damage after chemo: Potential risk factors revealed

Being older, overweight and having low hemoglobin levels (fewer red blood cells) could increase a patient's risk of developing debilitating nerve damage following chemotherapy, a research team led by UNSW Sydney has revealed.

Oncology & Cancer

Researchers illuminate potential precursors of blood cancers

Utah researchers report significant new insights into the development of blood cancers. In work published today in Blood Cancer Discovery, a journal of the American Association for Cancer Research, scientists describe an ...

Oncology & Cancer

Why some melanoma patients do not respond to immunotherapy

By harnessing the immune system against cancer, immunotherapies have revolutionized the way some types of cancer are treated. But most patients—across cancer types—do not respond, and in most cases, scientists are at ...

Oncology & Cancer

ASH issues guidance for preventing, treating VTE in cancer

(HealthDay)—In a clinical guideline from the American Society of Hematology, published online Feb. 11 in Blood Advances, recommendations are presented for the prevention and treatment of venous thromboembolism (VTE) in ...

page 1 from 40